Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Thoracic Surgery

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 83 articles:
HTML format
Text format



Single Articles


    December 2018
  1. BYRNE RA, Alfonso F, Schneider S, Maeng M, et al
    Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction
    Eur Heart J. 2018 Dec 5. pii: 5231946. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2018
  2. POTTS JE, Iliescu CA, Lopez Mattei JC, Martinez SC, et al
    Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States.
    Eur Heart J. 2018 Nov 30. pii: 5221009. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. CANDREVA A, Matter CM
    Is the amount of glow predicting the fire? Residual inflammatory risk after percutaneous coronary intervention.
    Eur Heart J. 2018 Nov 19. pii: 5173735. doi: 10.1093.
    PubMed     Text format    


  4. GOLWALA H, Cannon CP, Bhatt DL
    Reply to: Dual vs. triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Eur Heart J. 2018 Nov 5. pii: 5161202. doi: 10.1093.
    PubMed     Text format    


  5. GRAGNANO F, Calabro P, Valgimigli M
    Is triple antithrombotic therapy, or rather its duration and composition, the true culprit for the excess of bleeding events observed in patients with atrial fibrillation undergoing coronary intervention?
    Eur Heart J. 2018 Nov 5. pii: 5161206. doi: 10.1093.
    PubMed     Text format    


    October 2018
  6. FARAG M, Spinthakis N, Gue YX, Srinivasan M, et al
    Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study.
    Eur Heart J. 2018 Oct 30. pii: 5149701. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. KALKMAN DN, Aquino M, Claessen BE, Baber U, et al
    Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions.
    Eur Heart J. 2018 Oct 25. pii: 5144689. doi: 10.1093.
    PubMed     Text format     Abstract available


  8. YOON SH, Whisenant BK, Bleiziffer S, Delgado V, et al
    Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification.
    Eur Heart J. 2018 Oct 23. pii: 5143983. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2018
  9. STONE GW, Genereux P, Harrington RA, White HD, et al
    Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHA
    Eur Heart J. 2018 Sep 9. pii: 5093357. doi: 10.1093.
    PubMed     Text format     Abstract available


  10. MUKHERJEE D
    Coronary lesion complexity and the benefit of potent platelet inhibition after percutaneous coronary intervention.
    Eur Heart J. 2018 Sep 9. pii: 5093361. doi: 10.1093.
    PubMed     Text format    


    August 2018
  11. WINDECKER S, Neumann FJ, Juni P, Sousa-Uva M, et al
    Considerations for the choice between coronary artery bypass grafting and percutaneous coronary intervention as revascularization strategies in major categories of patients with stable multivessel coronary artery disease: an accompanying article of th
    Eur Heart J. 2018 Aug 25. pii: 5077827. doi: 10.1093.
    PubMed     Text format    


  12. PATEL NN, Murphy GJ
    Restrictive transfusion practice in cardiac surgery patients is safe, but what transfusion threshold is safe for my patient?
    Eur Heart J. 2018 Aug 21. pii: 5077325. doi: 10.1093.
    PubMed     Text format    


  13. SHEHATA N, Mistry N, da Costa BR, Pereira TV, et al
    Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis.
    Eur Heart J. 2018 Aug 10. pii: 5070413. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2018
  14. VARENNE O, Sinnaeve PR
    De-escalation of antiplatelet treatment after percutaneous coronary interventions for acute coronary syndromes: is less more?
    Eur Heart J. 2018 Jul 24. pii: 5057993. doi: 10.1093.
    PubMed     Text format    


    June 2018
  15. GARCIA-GARCIA HM, McFadden EP, Farb A, Mehran R, et al
    Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.
    Eur Heart J. 2018;39:2192-2207.
    PubMed     Text format     Abstract available


  16. SIBBING D, Gross L, Trenk D, Jacobshagen C, et al
    Age and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: results from the randomized TROPICAL-ACS trial.
    Eur Heart J. 2018 Jun 14. pii: 5037998. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. KEREIAKES DJ
    Healing by design: in vivo insights following contemporary coronary stent deployment.
    Eur Heart J. 2018 Jun 13. pii: 5037243. doi: 10.1093.
    PubMed     Text format    


    May 2018
  18. RABER L, Mintz GS, Koskinas KC, Johnson TW, et al
    Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions: Endorsed by the Chinese Society of Cardiology.
    Eur Heart J. 2018 May 22. pii: 5001185. doi: 10.1093.
    PubMed     Text format     Abstract available


  19. CREMER PC, Zhang Y, Alu M, Rodriguez LL, et al
    The incidence and prognostic implications of worsening right ventricular function after surgical or transcatheter aortic valve replacement: insights from PARTNER IIA.
    Eur Heart J. 2018 May 8. pii: 4993744. doi: 10.1093.
    PubMed     Text format     Abstract available


  20. MEIER B, Kaltenbach M
    The world's first 2 coronary angioplasty patients.
    Eur Heart J. 2018;39:1588-1589.
    PubMed     Text format    


    April 2018
  21. MAHMOUD KD, Jolly SS, James S, Dzavik V, et al
    Clinical impact of direct stenting and interaction with thrombus aspiration in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: Thrombectomy Trialists Collaboration.
    Eur Heart J. 2018 Apr 21. pii: 4975836. doi: 10.1093.
    PubMed     Text format     Abstract available


  22. GOLWALA HB, Cannon CP, Steg PG, Doros G, et al
    Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials.
    Eur Heart J. 2018 Apr 13. pii: 4970508. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  23. HULME W, Sperrin M, Curzen N, Kinnaird T, et al
    Operator volume is not associated with mortality following percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society registry.
    Eur Heart J. 2018 Mar 22. pii: 4951577. doi: 10.1093.
    PubMed     Text format     Abstract available


  24. CAPODANNO D, Buccheri S
    Operator volume and mortality in percutaneous coronary intervention: a call for better competency metrics.
    Eur Heart J. 2018 Mar 22. pii: 4951529. doi: 10.1093.
    PubMed     Text format    


  25. NICHOLLS M
    Andre Simon, cardiac & transplant surgeon.
    Eur Heart J. 2018;39:974-975.
    PubMed     Text format    


  26. AUFFRET V, Cottin Y, Leurent G, Gilard M, et al
    Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score.
    Eur Heart J. 2018 Mar 15. pii: 4938779. doi: 10.1093.
    PubMed     Text format     Abstract available


  27. AFZAL S, Kleinebrecht L, Hellhammer K, Veulemans V, et al
    First-in-man: successful interventional closure of severe paravalvular leakage after surgical rapid deployment aortic valve replacement.
    Eur Heart J. 2018 Mar 5. pii: 4920929. doi: 10.1093.
    PubMed     Text format    


    January 2018
  28. ZEITOUNI M, Silvain J, Guedeney P, Kerneis M, et al
    Periprocedural myocardial infarction and injury in elective coronary stenting.
    Eur Heart J. 2018 Jan 20. pii: 4815728. doi: 10.1093.
    PubMed     Text format     Abstract available


  29. SANGEN H, Imori Y, Tara S, Yamamoto T, et al
    Haemodynamic deterioration due to intra-aortic balloon counterpulsation in takotsubo cardiomyopathy.
    Eur Heart J. 2018 Jan 16. pii: 4812642. doi: 10.1093.
    PubMed     Text format    


  30. SMITH CR
    Emergency cardiac surgery following TAVI: implications for the future.
    Eur Heart J. 2018 Jan 8. pii: 4792978. doi: 10.1093.
    PubMed     Text format    


  31. KRISTENSEN SD, Maeng M, Capodanno D, Wijns W, et al
    The year in cardiology 2017: coronary interventions.
    Eur Heart J. 2018 Jan 2. pii: 4781700. doi: 10.1093.
    PubMed     Text format    


    December 2017
  32. EGGEBRECHT H, Vaquerizo B, Moris C, Bossone E, et al
    Incidence and outcomes of emergent cardiac surgery during transfemoral transcatheter aortic valve implantation (TAVI): insights from the European Registry on Emergent Cardiac Surgery during TAVI (EuRECS-TAVI).
    Eur Heart J. 2017 Dec 14. pii: 4745749. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2017
  33. ALKHOULI M, Carpenter E, Tarabishy A, Sengupta P, et al
    Annular rupture during transcatheter aortic valve replacement: novel treatment with amplatzer vascular plugs.
    Eur Heart J. 2017 Nov 13. doi: 10.1093.
    PubMed     Text format    


  34. LUSCHER TF
    Optimizing percutaneous coronary interventions: Heart Team, SYNTAX II Score, physiology and imaging guidance, modern stents, and guideline-based medication.
    Eur Heart J. 2017;38:3109-3113.
    PubMed     Text format    


  35. KUBO T, Shinke T, Okamura T, Hibi K, et al
    Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results.
    Eur Heart J. 2017;38:3139-3147.
    PubMed     Text format     Abstract available


    October 2017
  36. CASTANO A, Narotsky DL, Hamid N, Khalique OK, et al
    Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Eur Heart J. 2017;38:2879-2887.
    PubMed     Text format     Abstract available


    August 2017
  37. BYRNE RA, Stefanini GG, Capodanno D, Onuma Y, et al
    Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary.
    Eur Heart J. 2017 Aug 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  38. ESCANED J, Collet C, Ryan N, Luigi De Maria G, et al
    Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.
    Eur Heart J. 2017 Aug 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  39. RIBEIRO HB, Rodes-Cabau J, Blanke P, Leipsic J, et al
    Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry.
    Eur Heart J. 2017 Aug 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  40. D'ASCENZO F, Iannaccone M, Saint-Hilary G, Bertaina M, et al
    Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients.
    Eur Heart J. 2017 Aug 11. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2017
  41. DE WAHA S, Patel MR, Granger CB, Ohman EM, et al
    Relationship between microvascular obstruction and adverse events following primary primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials.
    Eur Heart J. 2017 Jul 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  42. ALFONSO F, Prati F
    Optical coherence tomography or intravascular ultrasound to optimize coronary stent implantation.
    Eur Heart J. 2017 Jul 25. doi: 10.1093.
    PubMed     Text format    


  43. VRANCKX P, Windecker S, Welsh RC, Valgimigli M, et al
    Thrombo-embolic prevention after transcatheter aortic valve implantation.
    Eur Heart J. 2017 Jul 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  44. SONDERGAARD L, De Backer O, Kofoed KF, Jilaihawi H, et al
    Natural history of subclinical leaflet thrombosis affecting motion in bioprosthetic aortic valves.
    Eur Heart J. 2017;38:2201-2207.
    PubMed     Text format     Abstract available


  45. GENEREUX P, Pibarot P, Redfors B, Mack MJ, et al
    Staging classification of aortic stenosis based on the extent of cardiac damage.
    Eur Heart J. 2017 Jul 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  46. WHITLOCK RP, McClure GR, Eikelboom JW
    Aortic valve replacement in younger patients.
    Eur Heart J. 2017 Jul 14. doi: 10.1093.
    PubMed     Text format    


    June 2017
  47. FALK V, Wohrle J, Hildick-Smith D, Bleiziffer S, et al
    Safety and efficacy of a repositionable and fully retrievable aortic valve used in routine clinical practice: the RESPOND Study.
    Eur Heart J. 2017 Jun 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  48. GERCKENS U, Tamburino C, Bleiziffer S, Bosmans J, et al
    Final 5-year clinical and echocardiographic results for treatment of severe aortic stenosis with a self-expanding bioprosthesis from the ADVANCE Study.
    Eur Heart J. 2017 Jun 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  49. WENDLER O, Schymik G, Treede H, Baumgartner H, et al
    SOURCE 3: 1-year outcomes post-transcatheter aortic valve implantation using the latest generation of the balloon-expandable transcatheter heart valve.
    Eur Heart J. 2017 Jun 12. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  50. ZITTERMANN A, Ernst JB, Prokop S, Fuchs U, et al
    Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily.
    Eur Heart J. 2017 May 12. doi: 10.1093.
    PubMed     Text format     Abstract available


  51. KORTELAND NM, Etnel JRG, Arabkhani B, Mokhles MM, et al
    Mechanical aortic valve replacement in non-elderly adults: meta-analysis and microsimulation.
    Eur Heart J. 2017 May 10. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2017
  52. HEAD SJ, Celik M, Kappetein AP
    Mechanical versus bioprosthetic aortic valve replacement.
    Eur Heart J. 2017 Apr 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  53. FRANZONE A, Pilgrim T, Arnold N, Heg D, et al
    Rates and predictors of hospital readmission after transcatheter aortic valve implantation.
    Eur Heart J. 2017 Apr 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  54. CAVALCANTE R, Sotomi Y, Mancone M, Whan Lee C, et al
    Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials.
    Eur Heart J. 2017 Apr 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  55. PALMERINI T, Della Riva D, Benedetto U, Bacchi Reggiani L, et al
    Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.
    Eur Heart J. 2017;38:1034-1043.
    PubMed     Text format     Abstract available


    March 2017
  56. VOLLEMA EM, Kong WK, Katsanos S, Kamperidis V, et al
    Transcatheter aortic valve thrombosis: the relation between hypo-attenuated leaflet thickening, abnormal valve haemodynamics, and stroke.
    Eur Heart J. 2017 Mar 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  57. VAN ROSENDAEL PJ, Kamperidis V, Kong WK, van Rosendael AR, et al
    Computed tomography for planning transcatheter tricuspid valve therapy.
    Eur Heart J. 2017;38:665-674.
    PubMed     Text format     Abstract available


  58. TARAMASSO M, Pozzoli A, Guidotti A, Nietlispach F, et al
    Percutaneous tricuspid valve therapies: the new frontier.
    Eur Heart J. 2017;38:639-647.
    PubMed     Text format     Abstract available


    February 2017
  59. NIELSEN LH, Botker HE, Sorensen HT, Schmidt M, et al
    Prognostic assessment of stable coronary artery disease as determined by coronary computed tomography angiography: a Danish multicentre cohort study.
    Eur Heart J. 2017;38:413-421.
    PubMed     Text format     Abstract available


    January 2017
  60. VAN ROSENDAEL PJ, van Wijngaarden SE, Kamperidis V, Kong WK, et al
    Integrated imaging of echocardiography and computed tomography to grade mitral regurgitation severity in patients undergoing transcatheter aortic valve implantation.
    Eur Heart J. 2017 Jan 10. pii: ehw612. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2016
  61. ABRAMOWITZ Y, Kazuno Y, Chakravarty T, Kawamori H, et al
    Concomitant mitral annular calcification and severe aortic stenosis: prevalence, characteristics and outcome following transcatheter aortic valve replacement.
    Eur Heart J. 2016 Dec 30. pii: ehw594. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2016
  62. TARANTINI G, Mojoli M, Urena M, Vahanian A, et al
    Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    September 2016
  63. MOAT N, Brecker S
    Transfemoral TAVI is superior to SAVR in elderly high-risk patients with symptomatic severe aortic stenosis!
    Eur Heart J. 2016.
    PubMed     Text format    


  64. LUSCHER TF
    Aortic valve disease 2016: evaluation for and outcome of TAVI and surgery.
    Eur Heart J. 2016;37:2615-7.
    PubMed     Text format    


  65. LUSCHER TF
    From heart failure to transplantation: genes, miRNAs, and biomarkers.
    Eur Heart J. 2016;37:2561-3.
    PubMed     Text format    


    August 2016
  66. LUSCHER TF
    Atrial fibrillation and stroke: risk factors, anticoagulation, and left atrial appendage occluders.
    Eur Heart J. 2016;37:2443-5.
    PubMed     Text format    


    July 2016
  67. SIONTIS GC, Praz F, Pilgrim T, Mavridis D, et al
    Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    June 2016
  68. VAHANIAN A, Nataf P
    Let us preserve the harmonious development of transcatheter aortic valve implantation!
    Eur Heart J. 2016.
    PubMed     Text format    


    May 2016
  69. PONIKOWSKI P, Voors AA, Anker SD, Bueno H, et al
    2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contributio
    Eur Heart J. 2016.
    PubMed     Text format    


  70. FIGULLA HR, Webb JG, Lauten A, Feldman T, et al
    The transcatheter valve technology pipeline for treatment of adult valvular heart disease.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    April 2016
  71. ABDELGHANI M, Soliman OI, Schultz C, Vahanian A, et al
    Adjudicating paravalvular leaks of transcatheter aortic valves: a critical appraisal.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    March 2016
  72. CLAVEL MA, Magne J, Pibarot P
    Low-gradient aortic stenosis.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  73. KODALI S, Thourani VH, White J, Malaisrie SC, et al
    Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  74. EGBE AC, Poterucha JT, Warnes CA
    Mixed aortic valve disease: midterm outcome and predictors of adverse events.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    February 2016
  75. SCHUELER R, Werner N, Nickenig G, Hammerstingl C, et al
    Catheter-based complete "Alfieri-Stich" via interventional annuloplasty and edge-to-edge repair for degenerative mitral regurgitation.
    Eur Heart J. 2016.
    PubMed     Text format    


    January 2016
  76. PURI R, Iung B, Cohen DJ, Rodes-Cabau J, et al
    TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  77. ZUK K, Stortecky S, Wenaweser P, Huber C, et al
    Mechanical aortic valves and massive mitral calcifications should not preclude transcatheter mitral Valve-In-Ring TAVI device implantation.
    Eur Heart J. 2016.
    PubMed     Text format    


  78. SAMAD Z, Vora AN, Dunning A, Schulte PJ, et al
    Aortic valve surgery and survival in patients with moderate or severe aortic stenosis and left ventricular dysfunction.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  79. BUDTS W, Roos-Hesselink J, Radle-Hurst T, Eicken A, et al
    Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology.
    Eur Heart J. 2016.
    PubMed     Text format    


  80. CRESPO-LEIRO MG, Stypmann J, Schulz U, Zuckermann A, et al
    Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    November 2015
  81. GLASER N, Jackson V, Holzmann MJ, Franco-Cereceda A, et al
    Aortic valve replacement with mechanical vs. biological prostheses in patients aged 50-69 years.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    September 2015
  82. ARSALAN M, Walther T, Smith RL 2nd, Grayburn PA, et al
    Tricuspid regurgitation diagnosis and treatment.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    June 2015
  83. ARZT S, Wilbring M, Knaut M
    Turned, wedged, but still no feeling: asymptomatic late transcatheter aortic valve dislocation into the LVOT.
    Eur Heart J. 2015.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Thoracic Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: